RSS0309
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
April 30, 2026
A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis
(clinicaltrials.gov)
- P2 | N=168 | Completed | Sponsor: Reistone Biopharma Company Limited | Active, not recruiting ➔ Completed
Trial completion • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
January 30, 2026
A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis
(clinicaltrials.gov)
- P2 | N=168 | Active, not recruiting | Sponsor: Reistone Biopharma Company Limited | Recruiting ➔ Active, not recruiting
Enrollment closed • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
September 23, 2025
A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis
(clinicaltrials.gov)
- P2 | N=168 | Recruiting | Sponsor: Reistone Biopharma Company Limited | Not yet recruiting ➔ Recruiting
Enrollment open • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
September 06, 2025
A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis
(clinicaltrials.gov)
- P2 | N=168 | Not yet recruiting | Sponsor: Reistone Biopharma Company Limited
New P2 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
1 to 4
Of
4
Go to page
1